首页 | 本学科首页   官方微博 | 高级检索  
     

miRNAs在甲状腺乳头状癌中的表达及临床病理意义
引用本文:戴璇璇,周毅力,刘超,闫东升,王瓯晨. miRNAs在甲状腺乳头状癌中的表达及临床病理意义[J]. 浙江医学, 2013, 35(20): 1802-1806
作者姓名:戴璇璇  周毅力  刘超  闫东升  王瓯晨
作者单位:[1]温州医科大学附属第一医院肿瘤外科,325000 [2]温州医科大学附属眼视光医院,325000
基金项目:浙江省自然科学基金资助项目(Y13H160115)
摘    要:目的:探讨甲状腺乳头状癌(PTC)中特征性的miRNA表达谱以及临床病理意义。方法对52例PTC及7例良性甲状腺肿瘤手术切除标本采用基因芯片技术及RNA印迹杂交法检测miRNA的表达,对过表达的miRNA表达水平与PTC临床病理特征之间的关系进行分析。结果(1)用基因芯片技术筛检发现 PTC 组织中5例过表达的 miRNAs(miR-375、miR-34a、miR-146b、miR-222、miR-31)。(2)RNA印迹杂交法验证芯片结果及检测其他miRNAs结果显示:miR-34a、miR-146b、miR-31、miR-21和miR-221在PTC组织中的表达水平较癌旁正常甲状腺组织显著升高(P<0.05)。MiR-146b和miR-221在PTC组织中的过表达率较良性甲状腺肿瘤组织显著升高(P<0.01)。PTC患者中包膜侵犯组、淋巴结转移组、TNM分期III- IV期组及AGES系统评分≥5分组miR-221的表达水平均明显高于相应对照组(P<0.05或0.01);而男性PTC患者的miR-146b表达水平明显高于女性PTC患者(P<0.05)。结论 miR-146b、miR-221、miR-21和miR-31的过表达与PTC的发生、发展有关;过表达的miR-221和miR-146b与PTC的预后不良有关。

关 键 词:甲状腺乳头状癌  微小RNA  芯片  RNA印迹杂交法

Expression of specific miRNAs in papillary thyroid carcinomas and their clinicopathological significance
Affiliation:DA I Xuanxuan, ZHOU Yili, L IU Chao, et al( Department of Surgical Oncology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China)
Abstract:Objective To investigate expression of specific miRNAs in papillary thyroid carcinoma (PTC) and their clini-copathological significance. Methods Fifty two surgical specimens of PTC tissues and 7 specimens of benign thyroid tumor tis-sues were col ected. The miRNA expression levels were detected by using microarray and Northern blot. The correlation between over- expressed miRNAs and clinicopathological features of PTC were analyzed. Results A set of 5 over- expressed miRNAs (miR- 375, miR- 34a, miR- 146b, miR- 222, miR- 31) was distinguished by microarray in PTC tissues compared to cancer- adja-cent tissues. Using Northern blot, the results of microarray were verified;and Northern blot results also showed that the expres-sion levels of miR- 34a, miR- 146b, miR- 31, miR- 221 and miR- 21 in PTC were significantly higher than those in cancer- adjacent tissues(P〈0.05). Additional y, the over- expression rates of miR- 146b and miR- 221 in PTC tissues were significantly higher than those in benign thyroid tumor tissues (P〈0.01). The expression levels of miR- 221 in PTC patients with extrathyroidal invasion, lymph node metastasis, advanced TNM stage (III- IV) and AGES score≥5 were significantly higher than those in control groups (P〈0.05 or 0.01);whereas the expression level of miR- 146b in male PTC patients was significantly higher than that in female PTC patients (P〈0.05). Conclusion Over- expression of miR- 146b, miR- 221, miR- 21, and miR- 31 may be associated with car-cinogenesis and progression of PTC, and the over- expression of miR- 221 and miR- 146b are also correlated with poor clinical outcome of PTC patients.
Keywords:Papillary thyroid carcinoma MiRNAs Microarray Northern blot
本文献已被 维普 等数据库收录!
点击此处可从《浙江医学》浏览原始摘要信息
点击此处可从《浙江医学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号